| Literature DB >> 35748372 |
Jaziel Ramos-Ortiz1, Hannah King2, Andrea L DeMaria2.
Abstract
Male-controlled contraception is limited, yet a promising hormonal male contraceptive (HMC) development in may increase options for men to share in the work of pregnancy prevention. This study examined college-aged (18-26 years) men's and women's perceptions of influential marketing strategy for an experimental novel HMC method, a transdermal gel. Six focus groups (n = 29) were conducted to glean insights for ad prototype creation. Ad prototypes were designed and then tested in semi-structured interviews (n = 20) to understand whether the messages were adequately representing the attributes intended while also allowing participants to contribute insights on improving appeal. A constant comparative approach was used for data contextualization and theme identification. Results provided a foundation for the creation of HMC message prototypes, aimed at increasing knowledge and uptake of a novel family planning method for men. Representation of a relatable character, or drawing on authentic experiences, aligned best with participant values. Focus groups illuminated salient concepts for HMC marketing, including humor, destigmatization, information, and credibility. Interview message testing yielded an understanding of elements participants responded most strongly to, including (1) ad sentiment and (2) trustworthiness. Findings provide a basis for understanding the placement of a potential marketing campaign to effectively frame HMC uptake as easy to use, safe, and popular while building on peer norms and group acceptability among a college-aged demographic. Healthcare providers and other practitioners can utilize these findings while engaging in family planning conversations, interventions, and message development.Entities:
Keywords: consumer behavior; health promotion; marketing; men’s health; reproductive health
Mesh:
Year: 2022 PMID: 35748372 PMCID: PMC9240595 DOI: 10.1177/15579883221094702
Source DB: PubMed Journal: Am J Mens Health ISSN: 1557-9883
Focus Group Protocol.
| Tell me about what you have heard about new hormonal male birth
control options, if anything? (There is currently a transdermal
gel undergoing clinical trials, you may have seen articles for
it on Facebook, Twitter, etc. Other clinical trials that have
occurred in the past included possibilities of an injection and
a pill.) |
Participant Demographics.
| ( | |
|---|---|
| Demographic Categories | |
| Age | 21.61±1.78 |
| Sex | |
| Female | 20 (40.82%) |
| Male | 29 (59.18%) |
| Race/Ethnicity | |
| White | 42 (85.71%) |
| Black | 3 (6.12%) |
| Hispanic/Latino | 1 (2.04%) |
| Asian/Pacific Islander | 2 (4.00%) |
| Middle Eastern/North African | 1 (2.04%) |
| Sexual orientation | |
| Heterosexual | 43 (87.76%) |
| Bisexual | 6 (12.24%) |
| Relationship status | |
| In an exclusive/monogamous relationship | 22 (44.89%) |
| Sexually active, but do not consider it a relationship | 13 (26.53%) |
| Not currently sexually active with another person | 11 (22.45%) |
| Have never been sexually active with another person | 3 (6.12%) |
| Primary contraceptive method
| |
| Male condom | 19 (38.78%) |
| Hormonal female contraception | 18 (36.73%) |
| Withdrawal | 7 (14.29%) |
| None | 2 (4.08%) |
Note. Results represented as M ± SD or n (%).
Values that do not add to sample total indicate missing data.
Prototype Attribute Matrix.
| Attribute dimensions | Attribute levels | |
|---|---|---|
| Option 1 | Option 2 | |
| Message strategy | Informational | Colloquial |
| Message/image relatability | Aspirational | Relatable |
| Message/image sentiment | Serious | Humorous |
| Perceived credibility | Image of Doctor | Other image |
Prototype Ratings.
| ( | |||
|---|---|---|---|
| Ad | Attribute | Median | |
| Ad 1 | Informational | 2.90 | 2.00 |
| Realistic | 5.15 | 5.00 | |
| Humorous | 7.85 | 8.00 | |
| Credible | 3.50 | 3.50 | |
| Ad 2 | Informational | 3.95 | 4.50 |
| Realistic | 7.20 | 7.50 | |
| Humorous | 1.20 | 1.00 | |
| Credible | 5.65 | 6.00 | |
| Ad 3 | Informational | 5.45 | 6.00 |
| Realistic | 7.45 | 8.00 | |
| Humorous | 2.95 | 2.50 | |
| Credible | 6.30 | 7.00 | |
| Ad 4 | Informational | 4.80 | 4.50 |
| Realistic | 7.55 | 8.00 | |
| Humorous | 3.35 | 4.00 | |
| Credible | 5.90 | 7.00 | |
| Ad 5 | Informational | 9.00 | 9.00 |
| Realistic | 8.10 | 8.00 | |
| Humorous | 1.20 | 1.00 | |
| Credible | 8.75 | 9.00 | |
| Ad 6 | Informational | 4.15 | 4.00 |
| Realistic | 6.60 | 6.50 | |
| Humorous | 1.75 | 1.00 | |
| Credible | 6.65 | 7.00 | |
Figure 1.Ad Prototypes.
Figure 2.Prototypes by Preference.